| Serial Number | 79357872 |
| Word Mark | C CANCER RESEARCH HORIZONS |
| Filing Date | Tuesday, July 5, 2022 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, January 2, 2024 |
| Registration Number | 7256888 |
| Registration Date | Tuesday, January 2, 2024 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, October 17, 2023 |
| Goods and Services | Organisation of community sporting and cultural events; arranging and conducting of conferences and seminars in the field of cancer prevention, diagnosis and treatment; education services, namely courses, seminars, workshops and conferences featuring subject matter related to alleviation, diagnosis, prevention and treatment of cancer; the publication of books, texts and magazines; developing and conducting educational programs in the fields of health, diet, nutrition, cancer and cancer prevention |
| Description of Mark | The mark consists of the literal elements "C CANCER RESEARCH HORIZONS" on a navy blue background, "CANCER RESEARCH HORIZONS" in white and "C" formed from an array of circles appearing in grey, royal blue, sky blue, and white. |
| Goods and Services | Pharmaceutical products for the diagnosis, prevention or treatment of cancer; cultures of cell media for medical and veterinary use; living cells for medical or veterinary use |
| Pseudo Mark | CANCER RESEARCH HORIZONS |
| Goods and Services | Charitable fundraising; Charitable collections in the nature of charitable fundraising; Organisation of charitable collections in the nature of charitable fundraising; charitable fundraising services by means of organisation of fundraising activities and events to support cancer research; providing financial grants for the purpose of research, diagnosis, treatment and prevention of cancer |
| Indication of Colors claimed | The color(s) navy blue, royal blue, sky blue, grey and white is/are claimed as a feature of the mark. |
| Goods and Services | promotion and advertising of products and services for others for the treatment of cancer; marketing of products and services for others for the treatment of cancer; business project management; business intermediary services in the nature of connecting buyers and sellers for the sale and purchase of goods and services for the treatment of cancer; business information services; providing an on-line commercial information directory for products and services for the treatment of cancer; providing advertising information featuring goods and services of others for the treatment of cancer via an on-line searchable database; business advisory services relating to the commercialisation of products and services for the treatment of cancer |
| Goods and Services | Chemicals for use in the pharmaceutical research, development or manufacturing industry; chemical preparations for use in the manufacture of pharmaceuticals; cultures of cell media for scientific and research use; media for cell culture for laboratory use in the biotechnological industry; media for cell culture for use in non-medical research laboratories; media for cell culture for use in medical research laboratories |
| Goods and Services | Licensing of intellectual property; licensing of intellectual property for use in the treatment of cancer |
| Goods and Services | Medical apparatus and instruments, namely for the diagnosis, prevention or treatment of cancer; surgical apparatus and instruments; diagnostic apparatus for medical purposes for the diagnosis or prevention of cancer |
| Disclaimer with Predetermined Text | "CANCER RESEARCH" |
| Goods and Services | Scientific and medical research services; providing medical and scientific research information relating to alleviation, diagnosis, prevention and treatment of cancer; Conducting research in the fields of health, diet, nutrition, cancer and cancer prevention; conducting clinical trials for others in the field of oncology; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; biomedical research services; laboratory research services relating to cancer and diagnosis, prevention or treatment thereof; medical research in the field of oncology; scientific advisory services relating to chemical reagents; scientific advisory services relating to biological reagents; Clinical or medical laboratory services relating to the production of monoclonal antibodies; laboratory research in the field of gene expression |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, December 19, 2022 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, December 19, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, December 19, 2022 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 102, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, December 19, 2022 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 036 - Insurance; financial affairs; monetary affairs; real estate affairs. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, December 19, 2022 |
| Primary Code | 036 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
| US Class Codes | 100, 101, 107 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, December 19, 2022 |
| Primary Code | 041 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, December 19, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, December 19, 2022 |
| Primary Code | 045 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Cancer Research Technology Limited |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Party Name | Cancer Research Technology Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Party Name | Cancer Research Technology Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Event Date | Event Description |
| Tuesday, April 9, 2024 | FINAL DISPOSITION NOTICE SENT TO IB |
| Tuesday, April 9, 2024 | FINAL DISPOSITION PROCESSED |
| Tuesday, April 2, 2024 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, January 2, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, January 2, 2024 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, October 17, 2023 | NOTIFICATION PROCESSED BY IB |
| Tuesday, October 17, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, October 17, 2023 | PUBLISHED FOR OPPOSITION |
| Wednesday, September 27, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, September 27, 2023 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, September 27, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Friday, September 8, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, September 8, 2023 | EXAMINER'S AMENDMENT ENTERED |
| Friday, September 8, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, September 8, 2023 | EXAMINERS AMENDMENT E-MAILED |
| Friday, September 8, 2023 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, August 29, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, August 28, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, August 28, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, July 4, 2023 | REFUSAL PROCESSED BY IB |
| Saturday, June 10, 2023 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Saturday, June 10, 2023 | REFUSAL PROCESSED BY MPU |
| Wednesday, April 26, 2023 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Tuesday, April 25, 2023 | NON-FINAL ACTION WRITTEN |
| Wednesday, April 19, 2023 | ASSIGNED TO EXAMINER |
| Friday, December 23, 2022 | APPLICATION FILING RECEIPT MAILED |
| Monday, December 19, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, December 17, 2022 | SN ASSIGNED FOR SECT 66A APPL FROM IB |